Antibody data
- Antibody Data
- Antigen structure
- References [30]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 25671-1-AP - Provider product page

- Provider
- Proteintech Group
- Product name
- CHCHD10 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated CHCHD10 antibody (Cat. #25671-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IF, IHC, IP, WB, ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Pregnancy precipitates metabolic imbalance and accelerates death in an animal model of mitochondrial cardiomyopathy.
Age-Associated Dysregulation of Postsynaptic Mitochondria Perturbs Reinnervation Kinetics.
LncRNA LINC00667 inhibits breast cancer progression by regulating POTEE to suppress mitochondrial oxidative phosphorylation.
CHCHD2 mutant mice link mitochondrial deficits to PD pathophysiology.
Longitudinal single-cell RNA sequencing reveals a heterogeneous response of plasma cells to colonic inflammation.
Expression profile of Chchd10 gene during testicular development.
Dysregulation of mitochondrial α-ketoglutarate dehydrogenase leads to elevated lipid peroxidation in CHCHD2-linked Parkinson's disease models.
Lineage plasticity of the integrated stress response is a hallmark of cancer evolution.
Amyloid fibril structures link CHCHD10 and CHCHD2 to neurodegeneration.
Clioquinol induces mitochondrial toxicity in SH-SY5Y neuroblastoma cells by affecting the respiratory chain complex IV and OPA1 dynamin-like GTPase.
Chchd10: A Novel Metabolic Sensor Modulating Adipose Tissue Homeostasis.
Loss of CHCHD2 Stability Coordinates with C1QBP/CHCHD2/CHCHD10 Complex Impairment to Mediate PD-Linked Mitochondrial Dysfunction.
Mitochondrial protein CHCHD10 inhibits NDV replication and reduces pathological changes.
High fat diet ameliorates mitochondrial cardiomyopathy in CHCHD10 mutant mice.
CHCHD2 mutant mice display mitochondrial protein accumulation and disrupted energy metabolism.
The identification of high-performing antibodies for Coiled-coil-helix-coiled-coil-helix domain containing protein 10 (CHCHD10) for use in Western Blot, immunoprecipitation and immunofluorescence.
CHCHD10 Modulates Thermogenesis of Adipocytes by Regulating Lipolysis.
Mouse midbrain dopaminergic neurons survive loss of the PD-associated mitochondrial protein CHCHD2.
Mutant CHCHD10 causes an extensive metabolic rewiring that precedes OXPHOS dysfunction in a murine model of mitochondrial cardiomyopathy.
Modulation of miR-181 influences dopaminergic neuronal degeneration in a mouse model of Parkinson's disease.
CHCHD2 and CHCHD10 regulate mitochondrial dynamics and integrated stress response.
Human Placental Endothelial Cell and Trophoblast Heterogeneity and Differentiation Revealed by Single-Cell RNA Sequencing.
TDP-43 and PINK1 mediate CHCHD10(S59L) mutation-induced defects in Drosophila and in vitro.
Loss of mitochondrial protein CHCHD10 in skeletal muscle causes neuromuscular junction impairment.
CHCHD10 is involved in the development of Parkinson's disease caused by CHCHD2 loss-of-function mutation p.T61I.
Single-cell transcriptomes reveal molecular specializations of neuronal cell types in the developing cerebellum.
PD-linked CHCHD2 mutations impair CHCHD10 and MICOS complex leading to mitochondria dysfunction.
Loss of CHCHD10-CHCHD2 complexes required for respiration underlies the pathogenicity of a CHCHD10 mutation in ALS.
CHCHD10 mutations p.R15L and p.G66V cause motoneuron disease by haploinsufficiency.
Loss of function CHCHD10 mutations in cytoplasmic TDP-43 accumulation and synaptic integrity.
Sayles NM, Casalena G, Zhao D, Dellinger RW, Holmes HE, Manzo O, Galkin A, Di Lorenzo A, Manfredi G
Molecular metabolism 2026 May;107:102352
Molecular metabolism 2026 May;107:102352
Age-Associated Dysregulation of Postsynaptic Mitochondria Perturbs Reinnervation Kinetics.
Guzman SD, Fraczek PM, Itsani K, Furati EK, Juros D, Kenney G, Valdez G, Chakkalakal JV, Aguilar CA
Aging cell 2026 Jan;25(1):e70355
Aging cell 2026 Jan;25(1):e70355
LncRNA LINC00667 inhibits breast cancer progression by regulating POTEE to suppress mitochondrial oxidative phosphorylation.
Yu Z, Xu K, Shang Y, Geng C, Zhang Y, Wang L
Cellular signalling 2025 Nov;135:112074
Cellular signalling 2025 Nov;135:112074
CHCHD2 mutant mice link mitochondrial deficits to PD pathophysiology.
Liao SC, Kano K, Phanse S, Nguyen M, Margolis E, Fu Y, X Meng J, Moutaoufik MT, Chatterton Z, Saccon T, Broderick K, Aoki H, Simms J, Suteja FX, Sei Y, Huang EJ, McAvoy K, Manfredi G, Halliday G, Babu M, Nakamura K
Science advances 2025 Nov 14;11(46):eadu0726
Science advances 2025 Nov 14;11(46):eadu0726
Longitudinal single-cell RNA sequencing reveals a heterogeneous response of plasma cells to colonic inflammation.
Wen X, Li W, Li S, Chen D, Zheng J, Wang X, Zhang C, Liu Y, Ning Y, Jia R, Li P, Ji M, Ji C, Li J, Guo W
International journal of biological macromolecules 2025 Mar;294:139307
International journal of biological macromolecules 2025 Mar;294:139307
Expression profile of Chchd10 gene during testicular development.
Jiang X, Sun S, Han F, Sun L, Gu J, Cao J, Liu J
Gene expression patterns : GEP 2025 Jun;55:119395
Gene expression patterns : GEP 2025 Jun;55:119395
Dysregulation of mitochondrial α-ketoglutarate dehydrogenase leads to elevated lipid peroxidation in CHCHD2-linked Parkinson's disease models.
Gao G, Shi Y, Deng HX, Krainc D
Nature communications 2025 Feb 26;16(1):1982
Nature communications 2025 Feb 26;16(1):1982
Lineage plasticity of the integrated stress response is a hallmark of cancer evolution.
Diao S, Zou JY, Wang S, Ghaddar N, Chan JE, Kim H, Poulain N, Koumenis C, Hatzoglou M, Walter P, Sonenberg N, Le Quesne J, Tammela T, Koromilas AE
bioRxiv : the preprint server for biology 2025 Feb 13;
bioRxiv : the preprint server for biology 2025 Feb 13;
Amyloid fibril structures link CHCHD10 and CHCHD2 to neurodegeneration.
Lv G, Sayles NM, Huang Y, Mancinelli C, McAvoy K, Shneider NA, Manfredi G, Kawamata H, Eliezer D
Nature communications 2025 Aug 2;16(1):7121
Nature communications 2025 Aug 2;16(1):7121
Clioquinol induces mitochondrial toxicity in SH-SY5Y neuroblastoma cells by affecting the respiratory chain complex IV and OPA1 dynamin-like GTPase.
Katsuyama M, Arakawa N, Yaoi T, Kimura E, Matsumoto M, Iwata K, Umemura A, Yabe-Nishimura C
FEBS letters 2025 Apr;599(8):1135-1145
FEBS letters 2025 Apr;599(8):1135-1145
Chchd10: A Novel Metabolic Sensor Modulating Adipose Tissue Homeostasis.
Wu X, Zhang Z, Li J, Zong J, Yuan L, Shu L, Cheong LY, Huang X, Jiang M, Ping Z, Xu A, Hoo RLC
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Apr;12(15):e2408763
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Apr;12(15):e2408763
Loss of CHCHD2 Stability Coordinates with C1QBP/CHCHD2/CHCHD10 Complex Impairment to Mediate PD-Linked Mitochondrial Dysfunction.
Ren YL, Jiang Z, Wang JY, He Q, Li SX, Gu XJ, Qi YR, Zhang M, Yang WJ, Cao B, Li JY, Wang Y, Chen YP
Molecular neurobiology 2024 Oct;61(10):7968-7988
Molecular neurobiology 2024 Oct;61(10):7968-7988
Mitochondrial protein CHCHD10 inhibits NDV replication and reduces pathological changes.
Yu X, Jiang H, Li J, Ding J, Wu T, Chen K, Ding Z, Xu X
Veterinary microbiology 2024 Mar;290:109986
Veterinary microbiology 2024 Mar;290:109986
High fat diet ameliorates mitochondrial cardiomyopathy in CHCHD10 mutant mice.
Southwell N, Manzo O, Bacman S, Zhao D, Sayles NM, Dash J, Fujita K, D'Aurelio M, Di Lorenzo A, Manfredi G, Kawamata H
EMBO molecular medicine 2024 Jun;16(6):1352-1378
EMBO molecular medicine 2024 Jun;16(6):1352-1378
CHCHD2 mutant mice display mitochondrial protein accumulation and disrupted energy metabolism.
Liao SC, Kano K, Phanse S, Nguyen M, Margolis E, Fu Y, Meng J, Moutaoufik MT, Chatterton Z, Aoki H, Simms J, Hsieh I, Suteja F, Sei Y, Huang EJ, McAvoy K, Manfredi G, Halliday G, Babu M, Nakamura K
bioRxiv : the preprint server for biology 2024 Aug 31;
bioRxiv : the preprint server for biology 2024 Aug 31;
The identification of high-performing antibodies for Coiled-coil-helix-coiled-coil-helix domain containing protein 10 (CHCHD10) for use in Western Blot, immunoprecipitation and immunofluorescence.
Ayoubi R, Alshafie W, Southern K, McPherson PS, Laflamme C, NeuroSGC/YCharOS/EDDU collaborative group
F1000Research 2023;12:403
F1000Research 2023;12:403
CHCHD10 Modulates Thermogenesis of Adipocytes by Regulating Lipolysis.
Ding M, Ma YJ, Du RQ, Zhou WY, Dou X, Yang QQ, Tang Y, Qian SW, Liu Y, Pan DN, Tang QQ, Liu Y
Diabetes 2022 Sep 1;71(9):1862-1879
Diabetes 2022 Sep 1;71(9):1862-1879
Mouse midbrain dopaminergic neurons survive loss of the PD-associated mitochondrial protein CHCHD2.
Nguyen MK, McAvoy K, Liao SC, Doric Z, Lo I, Li H, Manfredi G, Nakamura K
Human molecular genetics 2022 May 4;31(9):1500-1518
Human molecular genetics 2022 May 4;31(9):1500-1518
Mutant CHCHD10 causes an extensive metabolic rewiring that precedes OXPHOS dysfunction in a murine model of mitochondrial cardiomyopathy.
Sayles NM, Southwell N, McAvoy K, Kim K, Pesini A, Anderson CJ, Quinzii C, Cloonan S, Kawamata H, Manfredi G
Cell reports 2022 Mar 8;38(10):110475
Cell reports 2022 Mar 8;38(10):110475
Modulation of miR-181 influences dopaminergic neuronal degeneration in a mouse model of Parkinson's disease.
Stein CS, McLendon JM, Witmer NH, Boudreau RL
Molecular therapy. Nucleic acids 2022 Jun 14;28:1-15
Molecular therapy. Nucleic acids 2022 Jun 14;28:1-15
CHCHD2 and CHCHD10 regulate mitochondrial dynamics and integrated stress response.
Ruan Y, Hu J, Che Y, Liu Y, Luo Z, Cheng J, Han Q, He H, Zhou Q
Cell death & disease 2022 Feb 16;13(2):156
Cell death & disease 2022 Feb 16;13(2):156
Human Placental Endothelial Cell and Trophoblast Heterogeneity and Differentiation Revealed by Single-Cell RNA Sequencing.
Li H, Peng H, Hong W, Wei Y, Tian H, Huang X, Jia L, Zheng J, Duan T, He Q, Wang K
Cells 2022 Dec 25;12(1)
Cells 2022 Dec 25;12(1)
TDP-43 and PINK1 mediate CHCHD10(S59L) mutation-induced defects in Drosophila and in vitro.
Baek M, Choe YJ, Bannwarth S, Kim J, Maitra S, Dorn GW 2nd, Taylor JP, Paquis-Flucklinger V, Kim NC
Nature communications 2021 Mar 26;12(1):1924
Nature communications 2021 Mar 26;12(1):1924
Loss of mitochondrial protein CHCHD10 in skeletal muscle causes neuromuscular junction impairment.
Xiao Y, Zhang J, Shu X, Bai L, Xu W, Wang A, Chen A, Tu WY, Wang J, Zhang K, Luo B, Shen C
Human molecular genetics 2020 Jul 21;29(11):1784-1796
Human molecular genetics 2020 Jul 21;29(11):1784-1796
CHCHD10 is involved in the development of Parkinson's disease caused by CHCHD2 loss-of-function mutation p.T61I.
Mao C, Wang H, Luo H, Zhang S, Xu H, Zhang S, Rosenblum J, Wang Z, Zhang Q, Tang M, Shepard MJ, Wang X, Wang Y, Zhuang Z, Shi C, Xu Y
Neurobiology of aging 2019 Mar;75:38-41
Neurobiology of aging 2019 Mar;75:38-41
Single-cell transcriptomes reveal molecular specializations of neuronal cell types in the developing cerebellum.
Peng J, Sheng AL, Xiao Q, Shen L, Ju XC, Zhang M, He ST, Wu C, Luo ZG
Journal of molecular cell biology 2019 Aug 19;11(8):636-648
Journal of molecular cell biology 2019 Aug 19;11(8):636-648
PD-linked CHCHD2 mutations impair CHCHD10 and MICOS complex leading to mitochondria dysfunction.
Zhou W, Ma D, Sun AX, Tran HD, Ma DL, Singh BK, Zhou J, Zhang J, Wang D, Zhao Y, Yen PM, Goh E, Tan EK
Human molecular genetics 2019 Apr 1;28(7):1100-1116
Human molecular genetics 2019 Apr 1;28(7):1100-1116
Loss of CHCHD10-CHCHD2 complexes required for respiration underlies the pathogenicity of a CHCHD10 mutation in ALS.
Straub IR, Janer A, Weraarpachai W, Zinman L, Robertson J, Rogaeva E, Shoubridge EA
Human molecular genetics 2018 Jan 1;27(1):178-189
Human molecular genetics 2018 Jan 1;27(1):178-189
CHCHD10 mutations p.R15L and p.G66V cause motoneuron disease by haploinsufficiency.
Brockmann SJ, Freischmidt A, Oeckl P, Müller K, Ponna SK, Helferich AM, Paone C, Reinders J, Kojer K, Orth M, Jokela M, Auranen M, Udd B, Hermann A, Danzer KM, Lichtner P, Walther P, Ludolph AC, Andersen PM, Otto M, Kursula P, Just S, Weishaupt JH
Human molecular genetics 2018 Feb 15;27(4):706-715
Human molecular genetics 2018 Feb 15;27(4):706-715
Loss of function CHCHD10 mutations in cytoplasmic TDP-43 accumulation and synaptic integrity.
Woo JA, Liu T, Trotter C, Fang CC, De Narvaez E, LePochat P, Maslar D, Bukhari A, Zhao X, Deonarine A, Westerheide SD, Kang DE
Nature communications 2017 Jun 6;8:15558
Nature communications 2017 Jun 6;8:15558
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- mouse heart tissue were subjected to SDS PAGE followed by western blot with 25671-1-AP( CHCHD10 Antibody) at dilution of 1:600
- Other comments
- WB
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- Immunofluorescent analysis of A431 cells using 25671-1-AP( CHCHD10 Antibody) at dilution of 1:25 and Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L)
- Other comments
- IF
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- Immunohistochemistry of paraffin-embedded human heart tissue slide using 25671-1-AP( CHCHD10 Antibody) at dilution of 1:50 (under 10x lens)
- Other comments
- IHC